4. Diabetes Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Diabetes Drugs Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Insulin
5.3.2. Oral Hypoglycemic Drugs (anti-diabetes drugs)
5.3.3. Non-insulin Injectable Anti-diabetes Drugs
5.3.4. Others
5.3.5. Phase III (Market estimations by 2029)
5.3.5.1. ISLETS (National Institute of Health (NID) & Health Resource and Services Administration)
5.3.5.2. ORMD-0801 or Placebo (Oramed, Ltd. & Integrium)
5.3.5.3. Tauroursodeoxycholic Acid (TUDCA) (Juvenile Diabetes Research Foundation)
5.3.5.4. Others
5.3.6. Tabular Presentation of Phase II (Qualitative Information)
5.3.7. Tabular Presentation of Phase Phase I (Qualitative Information)
6. North America Diabetes Drugs Market, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
6.3.Diabetes Drugs Market: By Region, 2023-2033, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7. UK and European Union Diabetes Drugs Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.Diabetes Drugs Market: By Region, 2023-2033, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.1.5. France
7.3.1.5.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8. Asia Pacific Diabetes Drugs Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.Diabetes Drugs Market: By Region, 2023-2033, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.1.3. India
8.3.1.3.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
9. Latin America Diabetes Drugs Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
9.3.Diabetes Drugs Market: By Region, 2023-2033, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
10. Middle East and Africa Diabetes Drugs Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
10.3.Diabetes Drugs Market: By Region, 2023-2033, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Diabetes Drugs Market: By Therapy, 2023-2033, USD (Million)
11. Company Profile
11.1. AstraZeneca plc
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Biocon Limited
11.3. Boston Therapeutics, Inc.
11.4. Cadila Healthcare
11.5. Eli Lilly and Company
11.6. GlaxoSmithKline plc
11.7. Johnson & Johnson
11.8. Lupin Limited
11.9. Merck & Co., Inc.
11.10. Novartis International AG
11.11. Pfizer Inc.
11.12. Ranbaxy Laboratories Limited
11.13. Sanofi S.A.
11.14. Takeda Pharmaceutical Company Ltd.
